Avatar
The New York Times News source @nytimes.com · New York City 🇺🇸· 3w

#PharmaceuticalIndustry #DrugPricing #HealthcareReform

Link Preview
www.nytimes.com
How TrumpRx Drug Prices Compare With Those in Other Countries
Rebecca Robbins covers the pharmaceutical industry. She oversaw data collection from pharmacies in Canada, Denmark, France, Germany, Italy, Japan, Switzerland and Britain.
Avatar
Yahoo! Finance News source @ca.finance.yahoo.com · United States 🇺🇸· 3w

#MiddleEastConflict #HealthcareSupplyChain #Pharmaceuticals

Link Preview
ca.finance.yahoo.com
Analysis-Middle East war disrupts pharma air routes, risks cancer drugs supply
LONDON, March 16 (Reuters) - War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and forcing companies to reroute flights and find overland access into the region, industry executives said.
Avatar
Yahoo Sports News source @sports.yahoo.com · Playa Vista, Los Angeles 🇺🇸· 3w

#Pharmaceuticals #DrugDevelopment #HealthcareInnovation

Link Preview
sports.yahoo.com
The hidden infrastructure behind every prescription drug in 2026
The hidden infrastructure behind every prescription drug in 2026 A customer steps up to the counter at a neighborhood pharmacy.
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· 3w

#PharmaceuticalIndustry #HealthcareCosts #PrescriptionDrugs

Link Preview
www.yahoo.com
Advocates push lawmakers to end tax break for drug commercials, advertising
Advocates argue that some drug companies spend more on executive salaries, stock buybacks, and advertising than they do on research and development, while pharmaceutical companies claim rising prescription drug costs are driven by research and development expenses.
W
Washington Post News source @washingtonpost.com · Washington (state) 🇺🇸· 4w

#WeightLossDrugs #PharmaceuticalPricing #HealthcareAccessibility

Link Preview
www.washingtonpost.com
How GLP1s are changing the ways Americans buy medicine
Ashley Elizabeth Harden logged on recently from her home in small-town Louisiana and searched for a weight-loss drug. She found plenty of options and settled on a cheaper, imitation version of the name-brand drugs for $177 a month that she could buy without going through insurance.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· 4w

#Pharmaceuticals #FDA #HealthSafety

Link Preview
www.cbsnews.com
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Emily Mae Czachor is a reporter and news editor at CBSNews. com. She typically covers breaking news, extreme weather and issues involving social justice.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· 4w

#Pharma #Biotech #Innovation

Link Preview
www.forbes.com
Is China Pharma's New Cash Cow Or A Policy Risk?
Forbes contributors publish independent expert analyses and insights. An explosion of licensing deals between U. S. pharma and Chinese biotech firms in the past year could create a new level of reliance on China, just as the U.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· 4w

#ArtificialIntelligence #Pharmaceuticals #DrugManufacturing

Link Preview
www.forbes.com
How Lilly Used AI To Crank Up Production Of Its Popular GLP-1s
Forget the drug discovery hype. Here's how the world's largest pharma company is seeing a payoff from AI right now. here's been huge hype around AI's potential for drug discovery.
Avatar
CNBC News source @cnbc.com · New Jersey 🇺🇸· 4w

#Investing #Pharmaceuticals #Geopolitics

Link Preview
www.cnbc.com
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
The U. S. and Israel are showing signs of escalating their war against Iran - a move that could batter a variety of assets, even traditional safe havens.
Avatar
Newsweek News source @newsweek.com · New York 🇺🇸· 4w

#DrugPrices #Healthcare #Pharmaceuticals

Link Preview
www.newsweek.com
List of medications seeing major price changes in 2026
A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the manufacturers that made deals with the Trump administration to lower prices.
Avatar
The New York Times News source @nytimes.com · New York City 🇺🇸· Feb 27

#HenriettaLacks #MedicalEthics #PharmaceuticalIndustry

Link Preview
www.nytimes.com
Henrietta Lacks's Family Settles Suit With Novartis Over Use of Her Cells
The pharmaceutical giant Novartis has reached a settlement with the family of Henrietta Lacks, a Black woman whose cells were taken from her without her consent in 1951, when she was dying of cervical cancer in a segregated ward at Johns Hopkins Hospital in Baltimore.
Avatar
CNN News source @us.cnn.com · United States 🇺🇸· Feb 27

#HenriettaLacks #MedicalEthics #Pharmaceuticals

Link Preview
us.cnn.com
Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine | CNN
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 27

#HenriettaLacks #MedicalEthics #PharmaceuticalIndustry

Link Preview
www.cbsnews.com
Novartis settles with woman's estate over use of her "stolen" cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advances, including the polio vaccine.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 27

#HenriettaLacks #MedicalEthics #PharmaceuticalJustice

Link Preview
www.cbsnews.com
Novartis settles with Henrietta Lacks' estate over use of her "stolen" cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
Avatar
AP NEWS News source @apnews.com · New York City 🇺🇸· Feb 27

#HenriettaLacks #MedicalEthics #PharmaceuticalIndustry

Link Preview
apnews.com
Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine.
Avatar
CNBC News source @cnbc.com · New Jersey 🇺🇸· Feb 26

#Novartis #Pharmaceuticals #FDARegulations

Link Preview
www.cnbc.com
Novartis, Genentech file suit alleging illegal importation of prescription drug
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel on Sept. 9, 2025.
W
The Wall Street Journal News source @wsj.com · New York City 🇺🇸· Feb 25

#ObesityTreatment #PharmaceuticalNews #ClinicalTrials

Link Preview
www.wsj.com
Novo Nordisk, United Laboratories Say New Obesity Drug Helps Patients Lose Weight in Trial
Novo Nordisk and United Biotechnology's experimental obesity drug UBT251 achieved up to 19. 7% mean weight loss in a midstage China trial.
Avatar
CNBC News source @cnbc.com · New Jersey 🇺🇸· Feb 25

#NovoNordisk #Pharmaceuticals #Investing

Link Preview
www.cnbc.com
These 4 charts show the scale of Novo Nordisk's woes
Novo stock is down 75% since peaking at just over 1,000 Danish kroner a share in mid-2024, illustrating waning investor confidence.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· Feb 24

#OvertheCounter #DrugSafety #PharmaceuticalRegulation

Link Preview
www.forbes.com
What Makary's Plan For Expanding OTC Drug Access Could Mean For Safety
Marty Makary, commissioner of the Food and Drug Administration, said he believes "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring, or "if it could be used for some nefarious purpose.
Avatar
CNN News source @us.cnn.com · United States 🇺🇸· Feb 24

#Pharmaceuticals #WeightLoss #DiabetesMedication

Link Preview
us.cnn.com
Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 | CNN
Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027.